SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is seeing active discussion following reports regarding a partner's challenges in securing financing for a data center, a narrative largely countered by denials from the involved companies and speculation among traders about pre-earnings market manipulation.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is actively trending amid discussions of its strategic investments in AI-enabled defense systems and new product unveilings, with the community highly anticipating a potential short squeeze driven by significant call options activity and broader sector momentum in drone dominance programs.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as the Supreme Court struck down President Trump's sweeping tariffs, a ruling he called a "disgrace," prompting community debate over potential consumer refunds and his administration's next economic moves after this significant challenge to his trade policies.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is a focus of debate after its recent earnings showed massive ARR growth and its first positive adjusted EBITDA, yet some investors link its volatility to broader AI infrastructure funding challenges. Despite this, significant institutional accumulation and bullish analyst upgrades are driving a strong community conviction in its undervalued growth trajectory as a leading AI hyperscaler.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is highly volatile as the market digests the Supreme Court's ruling against tariffs and anticipates former President Trump's reaction, with the community divided on whether this signals reduced inflation and potential rate cuts or increased market uncertainty and new trade threats.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike (NKE) is trending as the community expresses confusion over its recent sell-off, with many attributing the decline to market manipulation or a "sell the news" event, despite discussions around potential tariff relief and the company's restructuring efforts including layoffs. Investors are actively debating if NKE is a value trap or a prime opportunity for a long-term turnaround, especially given broader sector comparisons and concerns over its recent performance in key markets.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending upward after the FDA reversed its refusal and agreed to review the company's seasonal flu vaccine application, fueling a community-driven short squeeze. This regulatory pivot has invigorated bullish sentiment, with many anticipating continued gains driven by optimism for Moderna's oncology pipeline and AI-powered drug development.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust Series 1 is trending as the Supreme Court's decision to strike down President Trump's broad tariffs sparks a volatile market reaction. While some investors see this as a catalyst for lower inflation, many in the community remain divided, speculating about new tariff implementations, potential multi-billion dollar refunds, and ongoing geopolitical tensions.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is buzzing as it unveils its new Indensity battery architecture, a modular, high-density solution targeted at critical grid and data center power needs. Speculation is rampant within the community ahead of an imminent business update, with many investors anticipating significant partnerships or announcements that could leverage the company's safe, US-made, long-duration energy storage technology to address growing power demands.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as its $100 million public offering, priced at $5.45 per share, and a $100 million royalty funding agreement with RTW Investments spark intense community debate. While bulls view this as a strategic move to secure runway for pipeline advancement and prostate cancer commercialization, bears voice strong concerns over significant dilution and management's timing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Recommendation of "Hold" by Brokerages

Amicus Therapeutics, Inc. (NASDAQ:FOLD - Get Free Report) has been given a consensus recommendation of "Hold" by the fourteen brokerages that are covering the stock, Marketbeat.com reports. One...

Principal Financial Group Inc. Has $2.08 Million Stock Holdings in Amicus Therapeutics, Inc. $FOLD

Principal Financial Group Inc. boosted its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 1,229.5% during the third quarter, according to its most recent disclosure with the...

What to Expect From These Drug/Biotech Players This Earnings Season?

Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal Pharmaceuticals as they prepare to report quarterly results this week.

Should Investors Buy, Sell or Hold Amicus Stock Ahead of Q4 Earnings?

FOLD heads into Q4 earnings with Galafold driving growth and Pombiliti + Opfolda aiding the top line. BioMarin is set to acquire the company for $4.8 billion.

New York State Common Retirement Fund Raises Stock Holdings in Amicus Therapeutics, Inc. $FOLD

New York State Common Retirement Fund raised its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 35.1% during the 3rd quarter, according to the company in its most recent Form...

Best Biotech Stocks To Watch Today - February 8th

Danaher, Vertex Pharmaceuticals, Medpace, Amicus Therapeutics, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...

Promising Biotech Stocks To Watch Now - February 7th

Biotech Stocks To Add to Your Watchlist - February 6th

Danaher, Amicus Therapeutics, Vertex Pharmaceuticals, Moderna, argenex, Medpace, and ImmunityBio are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...

Amicus Therapeutics (NASDAQ:FOLD) Sees Large Volume Increase - Time to Buy?

Amicus Therapeutics (NASDAQ:FOLD) Sees Strong Trading Volume - Here's Why...

Amicus Therapeutics (NASDAQ:FOLD) Share Price Passes Above 200 Day Moving Average - Should You Sell?

Amicus Therapeutics (NASDAQ:FOLD) Share Price Passes Above 200 Day Moving Average - Here's What Happened...

Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.

FOLD
Amicus Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FOLD News

FOLDAmicus Therapeutics Inc